Table 1 Descriptive statistics: prevalence or mean±s.d.
From: Cardiovascular calcification and subcortical bone demineralization in hypertension
Number of patients | 91 |
Men, % (n) | 69.2% (63) |
Age, y (min–max) | 63.5±4.9 (55–74) |
Vascular calcification | |
Ascending aorta, % (n) | 48.4% (44) |
Left common carotid, % (n) | 9.9% (9) |
Left carotid bifurcation, % (n) | 98.9.0% (90) |
Left internal carotid, % (n) | 58.4% (53) |
Right common carotid, % | 5.5% (5) |
Right carotid bifurcation, % (n) | 94.5% (86) |
Right internal carotid, % (n) | 46.1% (42) |
Abdominal aorta, % (n) | 18.7% (17) |
Cumulative score (min–max) | 3.94±1.58 (2–8) |
Bone mineral density (BMD) | |
Total BMD, mg cm−3 (min–max) | 320±49 (229–492) |
Low BMD (T-score<−1), % (n) | 83.5% (76) |
Cortical BMD, mg cm−3 (min–max) | 1081±45 (977–1200) |
Subcortical BMD, mg cm−3 (min–max) | 421±74 (285–728) |
Trabecular BMD, mg cm−3 (min–max) | 198±44 (85–328) |
Lab assessments | |
eGFR, ml min−1 × 1.73 m2 (min–max) | 82.7±11.9 (62–112) |
Plasma calcium, mg dl−1 (min–max) | 9.14±0.38 (8.5–10.3) |
Plasma albumin, g l−1 (min–max) | 39.9±3.8 (28–49) |
Normalized plasma calcium, mg dl−1 (min–max) | 9.19±0.71 (8.08–10.74) |
Plasma phosphorus, mg dl−1 (min–max) | 3.52±0.41 (2.50–4.14) |
Plasma parathyroid hormone, pg ml−1 (min–max) | 44.0±11.4 (13–66) |
Plasma 25(OH) vitamin D, ng ml−1 (min–max) | 36.3±7.3 (18–48) |
Other cardiovascular risk factors | |
Hypercholesterolemia, % (n) | 75.8% (69) |
Current Smoker, % (n) | 35.2% (32) |
Diabetes mellitus, % (n) | 39.6% (36) |
Blood pressure status | |
Systolic pressure, mm Hg (min–max) | 141±17 (122–196) |
Diastolic pressure, mm Hg (min–max) | 77±11 (62–108) |
Pulse pressure, mm Hg (min–max) | 64±17 (30–110) |
Thiazide diuretics, % (n) | 31.9% (29) |
Betablockers, % (n) | 82.4% (75) |
Calcium channel blockers, % (n) | 47.2% (43) |
Angiotensin converting enzyme inhibitors or angiotensin receptor blockers, % (n) | 92.3% (84) |
